Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | integrin alpha 3 | 0.0236 | 0.1989 | 0.2977 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0393 | 0.5178 | 0.5 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0393 | 0.5178 | 1 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0393 | 0.5178 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0393 | 0.5178 | 0.5 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0143 | 0.0095 | 0.0183 |
Loa Loa (eye worm) | hypothetical protein | 0.0393 | 0.5178 | 0.4845 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0393 | 0.5178 | 0.7749 |
Plasmodium vivax | RNA helicase-1, putative | 0.0393 | 0.5178 | 0.5 |
Echinococcus granulosus | integrin beta 2 | 0.0467 | 0.6682 | 1 |
Echinococcus granulosus | integrin alpha 3 | 0.0236 | 0.1989 | 0.2977 |
Loa Loa (eye worm) | integrin beta-2 | 0.063 | 1 | 1 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0307 | 0.3448 | 0.1886 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0393 | 0.5178 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 0.1926 | 0.1368 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0393 | 0.5178 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0393 | 0.5178 | 0.5 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0474 | 0.6833 | 0.6614 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0393 | 0.5178 | 0.7749 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0393 | 0.5178 | 0.7749 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0393 | 0.5178 | 0.5 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0143 | 0.0095 | 0.0183 |
Echinococcus multilocularis | integrin beta 2 | 0.0467 | 0.6682 | 1 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0393 | 0.5178 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0393 | 0.5178 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0393 | 0.5178 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.0371 | 0.4737 | 0.9147 |
Schistosoma mansoni | integrin alpha | 0.0307 | 0.3448 | 0.6659 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0393 | 0.5178 | 0.4028 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0393 | 0.5178 | 0.5 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0393 | 0.5178 | 0.5 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0393 | 0.5178 | 0.5 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0393 | 0.5178 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0241 | 0.2105 | 0.156 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0393 | 0.5178 | 1 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0393 | 0.5178 | 0.7749 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0393 | 0.5178 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC50 (functional) | = 79 uM | Lowest concentration to reduce viral effect by 50% or more against Rhinovirus (RV)-1A | ChEMBL. | 3005578 |
MIC50 (functional) | = 157 uM | Lowest concentration to reduce viral effect by 50% or more against Rhinovirus (RV)-2 | ChEMBL. | 3005578 |
MIC50 (functional) | = 157 uM | Lowest concentration to reduce viral effect by 50% or more against coxsackie virus A21 | ChEMBL. | 3005578 |
Toxicity (ADMET) | = 157 uM | Cytotoxicity concentration in HeLa cells | ChEMBL. | 3005578 |
Toxicity (ADMET) | = 157 uM | Cytotoxicity concentration in HeLa cells | ChEMBL. | 3005578 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.